china glp-1 has approved Pfizer's treatment ​Xianweiying for long-term weight management in overweight or ‌obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market China May Soon Approve Country's

Quick Answer: No, commercially available GLP-1 patches have not been proven effective and lack FDA approval for weight loss or diabetes management

Common side effects include: Nausea Vomiting Diarrhea Stomach pain Constipation Reduced appetite More serious risks may involve: Thyroid concerns Pancreatitis Gallbladder issues Vision changes Severe gastrointestinal (GI) complications Allergic reactions A healthcare provider should review your medical history before starting treatment

They state that their ingredients are grown on a certified organic/regenerative farm, and manufacturing is set up to preserve nutrient potency

This is because they are designed to be "glucose-dependent," meaning they only stimulate insulin release when blood sugar levels are elevated

What Is a GLP-1

Theres no data to support these, she says